-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H8jdQnLC5zk4Dab9KvDYAXla3YPht05K44+BtYKEl+mHR/pr3v+bIo+Ybh9UHDfm obl2xa1egkkMYaUw4XGZww== 0000708717-09-000002.txt : 20091102 0000708717-09-000002.hdr.sgml : 20091102 20091102155919 ACCESSION NUMBER: 0000708717-09-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091102 DATE AS OF CHANGE: 20091102 EFFECTIVENESS DATE: 20091102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALFACELL CORP CENTRAL INDEX KEY: 0000708717 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222369085 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-70871-7N FILM NUMBER: 091151166 BUSINESS ADDRESS: STREET 1: 300 ATRIUM DRIVE CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: 732-652-4525 MAIL ADDRESS: STREET 1: 300 ATRIUM DRIVE CITY: SOMERSET STATE: NJ ZIP: 08873 D 1 primary_doc.xml X0603 D LIVE 0000708717 ALFACELL CORP 300 ATRIUM DRIVE SOMERSET NJ 08873 732-652-4525 DELAWARE None None Corporation true Charles Muniz c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Executive Officer Director David Sidransky c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director John P. Brancaccio c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director Stephen K. Carter c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director Donald R. Conklin c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director Paul M. Weiss c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director Kuslima Shogen c/o Alfacell Corp., 300 Atrium Drive Somerset NJ 08873 Director Biotechnology Decline to Disclose 06 false 2009-10-19 false true true true false 0 3250000 3250000 0 false 8 0 0 0 Proceeds from the offering will be used for general working capital. false ALFACELL CORP /s/ Charles Muniz Charles Muniz President, CEO, CFO 2009-10-28 -----END PRIVACY-ENHANCED MESSAGE-----